DOP89: Infliximab and ustekinumab clearance during induction predicts post-induction endoscopic outcomes in patients with Crohn’s DiseaseECCO'22Year: 2022
Authors: Wang, Z.(1);Kantasiripitak, W.(1);Verstockt, B.(2,3);João, S.(2,3);Ferrante, M.(2,3);Declerck, P.(1);D’Haens, G.(4);Laharie, D.(5);Vermeire, S.(2,3);Dreesen, E.(1);
(1)KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(3)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(4)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(5)Université de Bordeaux, Department of Hepato-gastroenterology and Digestive Oncology, Bordeaux, France;
DOP90: Efficacy of the treat-to-target approach in modifying disease course with ustekinumab in patients with moderate-to-severe Crohn’s Disease: Results from the STARDUST trialECCO'22Year: 2022
Authors: Peyrin-Biroulet, L.(1);Vermeire, S.(2);D'Haens, G.R.(3);Panés, J.(4);Dignass, A.(5);Magro, F.(6,7);Le Bars, M.(8);Lahaye , M.(9);Nazar, M.(10);Ni, L.(11);Bravatà , I.(12);Lavie , F.(9);Daperno , M.(13);Lukáš , M.(14);Armuzzi , A.(15);Löwenberg , M.(3);Gaya , D.R.(16);Danese , S.(17); STARDUST
(1)University Hospital of Nancy- University of Lorraine- INSERM U1256 NGERE, Department of Hepato-Gastroenterology, Houdemont, France;(2)University Hospitals Leuven, Department of Gastroenterology & Hepatology, Leuven, Belgium;(3)Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;(4)Hospital Clinic of Barcelona- IDIBAPS- CIBERehd, Department of Gastroenterology, Barcelona, Spain;(5)Agaplesion Markus Hospital, Department of Medicine I, Frankfurt/Main, Germany;(6)Institute for Molecular and Cell Biology- Faculty of Medicine University of Porto, Department of Pharmacology & Therapeutics, Porto, Portugal;(7)Hospital de São João, Department of Gastroenterology, Porto, Portugal;(8)Janssen-Cilag, Medical Affairs, Issy-les-Moulineaux, France;(9)Janssen-Cilag BV, Medical Affairs, Breda, The Netherlands;(10)Janssen-Cilag Polska Sp. z o.o, Medical Affairs, Warsaw, Poland;(11)Janssen-Cilag Russia, Medical Affairs, Moscow, Russian Federation;(12)Janssen-Cilag, Medical Affairs, Milan, Italy;(13)Mauriziano Hospital, Gastroenterology Unit, Turin, Italy;(14)Clinical Center ISCARE, Clinical and Research Center for Inflammatory Bowel Diseases, Prague, Czech Republic;(15)Fondazione Policlinico Universitario A. Gemelli IRCCS, IBD Unit- Università Cattolica del Sacro Cuore, Rome, Italy;(16)Glasgow Royal Infirmary, Department of Gastroenterology, Glasgow, United Kingdom;(17)Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy;
N01: Type of patient education impacts the willingness to switch from an IV to SC of a biological in patients with Inflammatory Bowel Disease: a multicentre, comparative study.ECCO'22Year: 2022
Authors: De Dycker, E.(1);Hoefkens, E.(2);Asnong, K.(2);Geens, P.(1);Lembrechts, N.(2);Lambrechts, T.(1);Van de Schoot, I.(2);Paps, A.(2);Vermeire, S.(1);Pouillon, L.(2);Ferrante, M.(1);Bossuyt, P.(2);
(1)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)Imelda General Hospital Bonheiden, Department of Gastroenterology, Bonheiden, Belgium;
N02: The importance of the multidisciplinary team (MDT) and its impact on quality of life and medication adherence in patients with Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Herrerias, G.(1);Barros, J.R.(2);Lopes, M.A.(1);Saad-Hossne, R.(3);Baima, J.P.(4);Sassaki, L.Y.(4);
(1)São Paulo State University Unesp- Medical School- Botucatu, medical clinic department, Botucatu, Brazil;(2)Federal University of Rio de Janeiro- Macae- Brazil, Nursing Institute, Macaé/RJ, Brazil;(3)São Paulo State University Unesp- Medical School- Botucatu/SP, Department of surgery and orthopedics, Botucatu/SP, Brazil;(4)São Paulo State University Unesp- Medical School- Botucatu/SP, Department of Clinical Medicine, Botucatu/SP, Brazil;
N05: Patient involvement in inflammatory bowel disease therapy and disease-related parameters - is there an association?ECCO'22Year: 2022
Authors: Haj Natour, O.(1);Magnezi, R.(2);Ben Horin, S.(3);Lipkin, M.(3);Ungar, B.(3);Galper, A.(3);Sina, S.(3);Kopylov, U.(3);
(1)Tel-HaShomer Sheba Medical Center+ Bar Ilan University, Department of Gastroenterology, Ramat Gan, Israel;(2)Bar Ilan University, Department of Manegment, Ramat Gan, Israel;(3)Tel-HaShomer Sheba Medical Center, Department of Gastroenterology, Ramat Gan, Israel;
N06: Assessing stakeholder identified barriers and enablers to Ultrasound implementation for assessment of Crohn's Disease in the UK: A qualitative interview studyECCO'22Year: 2022
Authors: RadfordBSc- MSc- PGCert- PhD student, S.(1);Leighton, P.(2);Coad, J.(3);Moran, G.(1);
(1)Nottingham NIHR Biomedical Research Centre, Liver and Gastrointestinal Disorders Translational Medicine, Nottingham, United Kingdom;(2)The University of Nottingham, Faculty of Medicine, Nottingham, United Kingdom;(3)University of Nottingham, Faculty of Health Sciences, Nottingham, United Kingdom;
N08: The influence of the Covid-19 epidemic on access to medical advice for children with Inflammatory Bowel Disease (IBD), based on patients from The Children's Memorial Health Institute, Warsaw (IPCZD).ECCO'22Year: 2022
Authors: Kotkowicz Szczur, M.(1);Matuszczyk, M.(2);Kierkuś, J.(2);
(1)Instytut Pomnik Centrum Zdrowia Dziecka, Oddział Gastroenterologi- Hepatologii i Zaburzeń Karmienia, Warsaw, Poland;(2)The Children's Memorial Health Institute., Department of Gastroenterology- Hepatology- Feeding disorders and Pediatrics, Warsaw, Poland;
N09: Disease knowledge and quality of life perception in Inflammatory Bowel Disease: a randomised controlled trialECCO'22Year: 2022
Authors: MartinatoRN PhD, M.(1);Comoretto, R.I.(2);Monaco, E.(1);Ocagli, H.(1);Gregori, D.(1);
(1)University of Padova, Department of Cardiac- Thoracic- Vascular Sciences and Public Health, Padova, Italy;(2)University of Torino, Department of Public Health and Pediatric, Torino, Italy;
N11: Development of a young person clinic for 16-24-year-olds with Inflammatory Bowel Disease (IBD), using a multidisciplinary team (MDT) approach.ECCO'22Year: 2022
Authors: Hamzawi, M.(1);Hickey, Y.(1);Brannick, S.(1);Brett Kilmurray, O.(1);Jones, F.(1);Sheridan, J.(1);Cullen, G.(1);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;
N12: Systematic Review: The role of psychological stress in Inflammatory Bowel DiseaseECCO'22Year: 2022
Authors: Black, J.(1);Sweeney, L.(1);Yuan, Y.(1);Singh, H.(2);Norton, C.(1);Czuber-Dochan, W.(1);
(1)King's College London, Florence Nightingale Faculty of Nursing- Midwifery & Palliative Care, London, United Kingdom;(2)Study Advisory Group, n/a, London, United Kingdom;
N13: Clinical service delivery implications of the Covid-19 pandemic on people with inflammatory bowel disease: a qualitative studyECCO'22Year: 2022
Authors: Kemp, K.(1);Avery, P.(2);Bryant, R.(3);Cross, A.(4);Danter, K.(3);Kneebone, A.(5);Morris, D.(6);Walker, A.(7);Whitley, L.(8);Dibley, L.(9);
(1)Manchester Royal Infirmary, Gastroenterology, Manchester, United Kingdom;(2)St Mark's Hospital- Harrow, IBD Unit, London, United Kingdom;(3)Patient and Public Involvement Colleague, x, x, United Kingdom;(4)Gloucestershire Hospitals NHS Foundation Trust, Gastroenterology, Gloucester, United Kingdom;(5)Royal Bolton Hospital, Gastroenterology, Bolton, United Kingdom;(6)Lister Hospital, Endoscopy, Stevenage, United Kingdom;(7)South Warwickshire NHS Foundation Trust, Gastroenterology, Warwick, United Kingdom;(8)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom;
N14: Who can do it, if not me? - Identification of biopsychosocial predictors for the quality of life, satisfaction with life, and acceptance of the gastrointestinal diseaseECCO'22Year: 2022
Authors: Rudnik, A.(1);Piotrowicz, G.(2);Piotrowicz, A.(3);Bidzan, M.(4);Rydzewska, G.(5);
(1)University of Gdansk, Institute of Psychology, Gdańsk, Poland;(2)Independent Public Health Care of the Ministry of the Internal Affairs, Department of Gastroenterology-, Gdańsk, Poland;(3)Independent Public Health Care of the Ministry of the Internal Affairs, Department of Gastroenterology, Gdańsk, Poland;(4)University of Gdańsk, Institute of Psychology, Gdańsk, Poland;(5)Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw, Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Subdivision, Warsaw, Poland;
N15: Feedback from adolescents and parents on the transition process to an Irish Adult IBD serviceECCO'22Year: 2022
Authors: Hamzawi, M.(1);Brannick, S.(1);Hickey, Y.(1);Jones, F.(1);Brett Kilmurray, O.(1);Sheridan, J.(1);Cullen, G.(1);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;
N16: ‘Same storm, different boat’… Exploring the impact of the COVID-19 pandemic on patients with Inflammatory Bowel Disease, with or without shielding: a qualitative studyECCO'22Year: 2022
Authors: Kemp, K.(1);Avery, P.(2);Bryant, R.(3);Cross, A.(4);Danter, K.(3);Kneebone, A.(5);Morris, D.(6);Walker, A.(7);Whitley, L.(8);Dibley, L.(9);
(1)Manchester Royal Infirmary, Department of Gastroenterology, Manchester, United Kingdom;(2)St. Mark's Hospital, IBD Unit, London, United Kingdom;(3)Patient & Public Involvement Colleague, x, x, United Kingdom;(4)Gloucestershire Hospitals NHS Foundation Trust, Gastroenterology, Gloucester, United Kingdom;(5)Royal Bolton Hospital, Gastroenterology, Bolton, United Kingdom;(6)Lister Hospital, Endoscopy, Stevenage, United Kingdom;(7)South Warwickshire NHS Foundation Trust, Gastroenterology, Warwick, United Kingdom;(8)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(9)University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom;
N17: Co Design of young person’s IBD clinic for 16-24 year oldsECCO'22Year: 2022
Authors: Hamzawi, M.(1);Brannick, S.(2);Hickey, Y.(2);Cullen, G.(2);Sheridan, J.(2);
(1)St Vincent's University Hospital, Department of Gastroenterology, Dublin, Ireland;(2)St Vincent's University Hospital, Gastroenterology, Dublin, Ireland;
N18: Introduction of inflammatory bowel disease specialized dietitian and nutritional status in a multidisciplinary IBD teamECCO'22Year: 2022
Authors: Hoekx, S.(1);Vanderstappen, J.(1);Wellens, J.(1);Verstockt, B.(1);Marc, F.(1);Vermeire, S.(1);Guedelha Sabino, J.(1);
(1)KU Leuven, Gastroenterology, Leuven, Belgium;
